NDC 0002-6103 – Zepbound
Tirzepatide 8.33 mg/mL · Injection, Solution · Subcutaneous
Product NDC0002-6103
Product details
- Brand name
- Zepbound
- Generic name
- Tirzepatide
- Labeler
- Eli Lilly and Company
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- NDA · NDA217806
- Marketed since
- January 7, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- GLP-1 Receptor Agonist; Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
Active ingredients
- Tirzepatide 8.33 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0002-6103-11 | 1 VIAL, MULTI-DOSE in 1 CARTON (0002-6103-11) / 2.4 mL in 1 VIAL, MULTI-DOSE (0002-6103-01) | Jan 7, 2026 |
Other Zepbound products
- 0002-2506 Tirzepatide 2.5 mg/.5mL · Injection, Solution · Eli Lilly and Company
- 0002-6612 Tirzepatide 25 mg/mL · Injection, Solution · Eli Lilly and Company
- 0002-6523 Tirzepatide 20.8 mg/mL · Injection, Solution · Eli Lilly and Company
- 0002-6304 Tirzepatide 16.7 mg/mL · Injection, Solution · Eli Lilly and Company
- 0002-6210 Tirzepatide 12.5 mg/mL · Injection, Solution · Eli Lilly and Company
- 0002-6052 Tirzepatide 4.17 mg/mL · Injection, Solution · Eli Lilly and Company
- 0002-3566 Tirzepatide 4.17 mg/mL · Injection, Solution · Eli Lilly and Company
- 0002-3555 Tirzepatide 8.33 mg/mL · Injection, Solution · Eli Lilly and Company
- 0002-3544 Tirzepatide 12.5 mg/mL · Injection, Solution · Eli Lilly and Company
- 0002-3533 Tirzepatide 16.7 mg/mL · Injection, Solution · Eli Lilly and Company
- 0002-3522 Tirzepatide 20.8 mg/mL · Injection, Solution · Eli Lilly and Company
- 0002-3511 Tirzepatide 25 mg/mL · Injection, Solution · Eli Lilly and Company